99 related articles for article (PubMed ID: 32262960)
1. Design and application of a smart nanodevice by combining cationic drug delivery and hyperthermia for cancer apoptosis.
Ramachandra Kurup Sasikala A; Unnithan AR; Park CH; Kim CS
J Mater Chem B; 2016 Jan; 4(4):785-792. PubMed ID: 32262960
[TBL] [Abstract][Full Text] [Related]
2. Drug-loaded liposome-capped mesoporous core-shell magnetic nanoparticles for cellular toxicity study.
Sharifabad ME; Mercer T; Sen T
Nanomedicine (Lond); 2016 Nov; 11(21):2757-2767. PubMed ID: 27759497
[TBL] [Abstract][Full Text] [Related]
3. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
4. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
6. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
Small; 2017 Jan; 13(2):. PubMed ID: 27735129
[TBL] [Abstract][Full Text] [Related]
7. Investigation of magnetic silica with thermoresponsive chitosan coating for drug controlled release and magnetic hyperthermia application.
Pon-On W; Tithito T; Maneeprakorn W; Phenrat T; Tang IM
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():23-30. PubMed ID: 30678907
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin loaded dual pH- and thermo-responsive magnetic nanocarrier for combined magnetic hyperthermia and targeted controlled drug delivery applications.
Hervault A; Dunn AE; Lim M; Boyer C; Mott D; Maenosono S; Thanh NT
Nanoscale; 2016 Jun; 8(24):12152-61. PubMed ID: 26892588
[TBL] [Abstract][Full Text] [Related]
9. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin hydrochloride - Loaded electrospun chitosan/cobalt ferrite/titanium oxide nanofibers for hyperthermic tumor cell treatment and controlled drug release.
Radmansouri M; Bahmani E; Sarikhani E; Rahmani K; Sharifianjazi F; Irani M
Int J Biol Macromol; 2018 Sep; 116():378-384. PubMed ID: 29723626
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional magnetopolymersomes of iron oxide nanoparticles and carboxymethylcellulose conjugated with doxorubicin for hyperthermo-chemotherapy of brain cancer cells.
Carvalho SM; Leonel AG; Mansur AAP; Carvalho IC; Krambrock K; Mansur HS
Biomater Sci; 2019 Apr; 7(5):2102-2122. PubMed ID: 30869664
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of doxorubicin and CoFe
Bahmani E; Banihashem S; Shirinzad S; Bybordi S; Shikhi-Abadi PG; Jazi FS; Irani M
Int J Pharm; 2024 Jan; 649():123618. PubMed ID: 37977290
[TBL] [Abstract][Full Text] [Related]
13. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
[TBL] [Abstract][Full Text] [Related]
16. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-Loaded Thermoresponsive Superparamagnetic Nanocarriers for Controlled Drug Delivery and Magnetic Hyperthermia Applications.
Ferjaoui Z; Jamal Al Dine E; Kulmukhamedova A; Bezdetnaya L; Soon Chang C; Schneider R; Mutelet F; Mertz D; Begin-Colin S; Quilès F; Gaffet E; Alem H
ACS Appl Mater Interfaces; 2019 Aug; 11(34):30610-30620. PubMed ID: 31359758
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional graphene-based magnetic nanocarriers for combined hyperthermia and dual stimuli-responsive drug delivery.
Rodrigues RO; Baldi G; Doumett S; Garcia-Hevia L; Gallo J; Bañobre-López M; Dražić G; Calhelha RC; Ferreira ICFR; Lima R; Gomes HT; Silva AMT
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():206-217. PubMed ID: 30274052
[TBL] [Abstract][Full Text] [Related]
19. AIEgen-Functionalized Mesoporous Silica Gated by Cyclodextrin-Modified CuS for Cell Imaging and Chemo-Photothermal Cancer Therapy.
Li QL; Wang D; Cui Y; Fan Z; Ren L; Li D; Yu J
ACS Appl Mater Interfaces; 2018 Apr; 10(15):12155-12163. PubMed ID: 29261277
[TBL] [Abstract][Full Text] [Related]
20. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
